Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Heart Failure: NICE Guideline

Practical GP

F. Florido

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Heart Failure in Women: 2025 Update

Scripps Health

M. Kittleson

Diabetes and Chronic Kidney Disease

Scripps Health

C. Mende

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Boost Your Heart Health With the Power of Nutrition

Baystate Health

B. Sarrette

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit